Gorman-Rupp Company (GRC) 25.77 $GRC Xylem's (XYL)

New Post Public Reply Private Reply Replies (0) Message Board

Sep 19, 2016 at 5:19 PM

Gorman-Rupp Company (GRC) 25.77 $GRC

Xylem's (XYL) Growth Prospects Bright Despite Macro Risks
Zacks Equity Research - Zacks Investment Research - 52 mins ago
On Sep 19, 2016, we issued an updated research report on premium diversified machinery company, Xylem Inc. (XYL).
NDSN: 97.53 (+1.25), XYL: 50.53 (+0.57), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Illinois Tool Works (ITW) Well Poised on Solid Fundamentals
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 7:34AM CDT
We issued an updated research report on Illinois Tool Works Inc. (ITW) on Sep 16, 2016.
TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), ITW: 117.16 (+0.97), DXPE: 25.33 (-0.62)

Deere (DE) Announces Changes in Senior Management Team
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 8:04AM CDT
Deere (DE) has announced changes to its senior management team.
BERY: 44.66 (+0.38), DE: 82.11 (+0.16), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Graco Inc. Lowered to a Strong Sell on Dreary Prospects
Zacks Equity Research - Zacks Investment Research - Mon Sep 12, 7:29AM CDT
Zacks Investment Research downgraded Graco Inc. (GGG) to a Zacks Rank #5 (Strong Sell) on Sep 10, 2016.
TNC: 63.79 (+0.46), GGG: 73.91 (+0.50), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Stanley Black & Decker's Prospects Solid, Risks Remain
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 8:55AM CDT
We have issued an updated research report on Stanley Black & Decker, Inc. (SWK) on Sep 6, 2016.
SWK: 121.26 (+1.14), TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Colfax's Growth Potential Solid, Near-Term Risks Remain
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 7:06AM CDT
We have issued an updated research report on Colfax Corporation (CFX) on Sep 5, 2016.
NDSN: 97.53 (+1.25), CFX: 28.33 (+0.21), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Standex International Now a Strong Sell on Weak Prospects
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 7:01AM CDT
Zacks Investment Research downgraded Standex International Corporation (SXI) to a Zacks Rank #5 (Strong Sell) on Sep 6, 2016.
NDSN: 97.53 (+1.25), GRC: 25.77 (+0.01), SXI: 87.88 (+1.27), DXPE: 25.33 (-0.62)

Tennant Expands in Mexico with Dofesa Barrido Acquisition
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 7:36AM CDT
Tennant Company (TNC) has strengthened its emerging market business by acquiring the assets of its prominent Mexican distributor, Dofesa Barrido Mecanizado (???Dofesa???).
NDSN: 97.53 (+1.25), TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Nordson Spurs Fluid Management Business with LinkTech Buy
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 6:05AM CDT
Nordson Corporation (NDSN) recently announced the acquisition of Ventura, California-based LinkTech Quick Couplings, Inc. Financial terms of the transaction were kept under wraps.
NDSN: 97.53 (+1.25), TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Barnes Group Strengthens Molds Business with FOBOHA Buy
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 5:37AM CDT
Barnes Group Inc. ( announced that it has substantially completed the acquisition of Adval Tech's molds business, except for the latter's Chinese operations due to pending regulatory approvals.
TNC: 63.79 (+0.46), B: 39.05 (+0.46), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Sun Hydraulics Lowered to Strong Sell on Weak Q3 Prospects
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 6:50AM CDT
Zacks Investment Research downgraded Sun Hydraulics Corp. (SNHY) to a Zacks Rank #5 (Strong Sell) on Aug 31, 2016.
TNC: 63.79 (+0.46), SNHY: 29.73 (+0.18), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Stock Market News for August 30, 2016
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:10AM CDT
Benchmarks finished higher on Monday, mostly helped by gains in financial stocks
HRS: 89.52 (+0.16), T: 40.06 (-0.14), C: 46.59 (+0.18), DIS: 92.63 (+0.07), GRC: 25.77 (+0.01), RBA: 34.51 (+0.46), BAC: 15.59 (+0.10), WFC: 46.01 (+0.58), CAT: 81.88 (-0.17), VZ: 51.20 (-0.68), TWX: 75.71 (+0.86)

Gorman-Rupp's Patterson Pump Intends to Buy Morrison
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 6:25AM CDT
Gorman-Rupp Co. (GRC) recently announced that its subsidiary, Patterson Pump Company has communicated its intention to acquire Florida-based Morrison Pump Company through a letter of intent.
TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), ITW: 117.16 (+0.97), DXPE: 25.33 (-0.62)

Gorman-Rupp Announces Subsidiary's Planned Acquisition
BusinessWire - Mon Aug 29, 3:30PM CDT
The Gorman-Rupp Company (NYSE MKT: GRC) announces that its wholly-owned subsidiary, Patterson Pump Company ("Patterson"

, has completed a letter of intent for its acquisition of the business of Morrison Pump Company ("Morrison"

based in Hollywood, Florida. The terms of the planned asset purchase are undisclosed.
GRC: 25.77 (+0.01)

Applied Industrial Braves Headwinds with Website Launch
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:38AM CDT
Applied Industrial Technologies, Inc. (AIT) unleashes a new approach to capture market demand by launching a brand new e-commerce website.
NDSN: 97.53 (+1.25), GRC: 25.77 (+0.01), AIT: 46.13 (+0.13), DXPE: 25.33 (-0.62)

Altra Industrial's Growth Potential Overshadowed by Risks
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:11AM CDT
We issued an updated research report on Altra Industrial Motion Corp. (AIMC) on Aug 26, 2016.
NDSN: 97.53 (+1.25), GRC: 25.77 (+0.01), AIMC: 27.05 (+0.37), DXPE: 25.33 (-0.62)

Nordson Corporation Now a Strong Buy on Solid Q3 & Outlook
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:08AM CDT
Zacks Investment Research upgraded Nordson Corporation (NDSN) to a Zacks Rank #1 (Strong Buy) on Aug 26, 2016.
NDSN: 97.53 (+1.25), TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), DXPE: 25.33 (-0.62)

Dover (DOV) Hits 52-Week High on Improving Energy Segment
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:22AM CDT
Dover (DOV) has hit a fresh 52-week high of $74.90 on Aug 23.
TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), DOV: 68.68 (+0.74), DXPE: 25.33 (-0.62)

Illinois Tool Works Hits 52-Week High on Bright Prospects
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:08AM CDT
Shares of Illinois Tool Works Inc. (ITW) reached a new 52-week high of $120.50 on Aug 23, before closing the trading session slightly lower at $119.78. This apex improved upon the last 52-week high of $119.84 on Aug 19.
TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), ITW: 117.16 (+0.97), DXPE: 25.33 (-0.62)

Should RBC Bearings (ROLL) Be in Your Portfolio Now?
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:07AM CDT
On Aug 24, 2016, Zacks Investment Research upgraded RBC Bearings Inc. (ROLL) to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell).
TNC: 63.79 (+0.46), GRC: 25.77 (+0.01), ROLL: 74.78 (+0.45), DXPE: 25.33 (-0.62)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...